TCDD induces CYP1A4 and CYP1A5 in chick liver and kidney and only CYP1A4, an enzyme lacking arachidonic acid epoxygenase activity, in myocardium and vascular endothelium

Toxicology and Applied Pharmacology

Volumn 164, Issue 1, 2000, Pages 24-37

  Gannon, Maureen ^a   Gilday, Deidre ^a   Rifkind, Arleen B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin; Arachidonic acid epoxygenation, dioxin induced; Cardiac myocytes, CYP1A induction in; Cell specific CYP expression; Chick, CYP1A induction in; CYP1A4 and CYP1A5; Immunohistochemistry; In situ hybridization; Vascular endothelial cells, CYP1A induction in

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ARACHIDONIC ACID EPOXYGENASE; CYTOCHROME P450 CYA1A5; CYTOCHROME P450 CYP1A4; CYTOCHROME P450 ISOENZYME; ETHOXYRESORUFIN DEETHYLASE; MESSENGER RNA; OXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; NONHUMAN; PROTEIN EXPRESSION; SPECIES DIFFERENCE; TISSUE SPECIFICITY;

ANIMALIA; MAMMALIA;

EID: 0034177851     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8864     Document Type: Article

References (47)

1. Adeagbo A. S. O. Endothelium-derived hyperpolarizing factor characterization as a cytochrome P4501A-linked metabolite of arachidonic acid in perfused rat mesenteric prearteriolar bed. Am. J. Hypertens. 10:1997;763-771.
2. Anderson L. M., Ward J. M., Park S. S., Jones A. B., Junker J. L., Gelboin H. V., Rice J. M. Immunohistochemical determination of inducibility phenotype with a monoclonal antibody to a methylcholanthrene-inducible isozyme of cytochrome P-450. Cancer Res. 47:1987;6079-6085.
3. Annas A., Brunstrom B., Brandt I., Brittelo E. B. Induction of ethoxyresorufin O-deethylase (EROD) and endothelial activation of the heterocyclic amine Trp-P-1 in bird embryo hearts. Arch. Toxicol. 72:1998;402-410.
4. Bisaha J. G., Bader D. Identification and characterization of a ventricular-specific avian myosin heavy chain, VMHC1: Expression in differentiating cardiac and skeletal muscle. Dev. Biol. 148:1991;355-364.
5. Canga L., Levi R., Rifkind A. B. Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: Decreased β-adrenergic responsiveness and evidence of increased intracellular calcium. Proc. Natl. Acad. Sci. USA. 85:1988;905-909.
6. Canga L., Paroli L., Blanck T. J. J., Silver R. B., Rifkind A. B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. Mol. Pharmacol. 44:1993;1142-1151.
7. Capdevila J. H., Falck J. R., Dishman E., Karara A. Cytochrome P-450 arachidonate oxygenase. Methods Enzymol. 187:1990a;385-394.
8. Capdevila J. H., Karara A., Waxman D. J., Martin M. V., Falck J. R., Guengerich F. P. Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J. Biol. Chem. 265:1990b;10865-10871.
9. Chen G., Cheung D. W. Modulation of endothelium-dependent hyperpolarization and relaxation to acetylcholine in rat mesenteric artery by cytochrome P450 enzyme activity. Circ. Res. 79:1996;827-833.
10. Copenhaver W. M., Kelly D. E., Wood R. L. Bailey's Textbook of Histology. 1978;Williams and Wilkins, Baltimore. p. 585-587.
11. Dees J. H., Masters B. S. S., Muller-Eberhard U., Johnson E. F. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital on the occurrence and distribution of four cytochrome P-450 isozymes in rabbit kidney, lung and liver. Cancer Res. 42:1982;1423-1432.
12. Diliberto J. J., Burgin D. E., Birnbaum L. S. Effects of CYP1A2 on disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,4,7,8-pentachlorodibenzofuran, and 2,2′,4,4′5,5′-hexachlorobiphenyl in CYP1A2 knockout and parental (C57BL/6N and 129/Sv) strains of mice. Toxicol. Appl. Pharmacol. 159:1999;52-64.
13. Foster J. R., Elcombe C. R., Boobis A. R., Davies D. S., Sesardic D., McQuade J., Robson R. T., Hayward C., Lock E. A. Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 c. Biochem. Pharm. 35:1986;4543-4554.
14. Gilday D., Bellward G. D., Sanderson J. T., Janz D. M., Rifkind A. B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic cytochrome P450-dependent arachidonic acid epoxygenation in diverse avian orders: Regioisomer selectivity and immunochemical comparison of the TCDD-induced P450s to CYP1A4 and 1A5. Toxicol. Appl. Pharmacol. 150:1998;106-116.
15. Gilday D., Gannon M., Yutzey K., Bader D., Rifkind A. B. Molecular cloning and expression of two novel avian cytochrome P4501A enzymes induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 271:1996;33054-33059.
16. Gourdie R. G., Mima T., Thompson R. P., Mikawa T. Terminal diversification of the myocyte lineage generates Purkinje fibers of the cardiac conduction system. Development. 121:1995;1423-1431.
17. Hamilton J. W., Denison M. S., Bloom S. E. Development of basal and induced aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity in the chicken embryo in ovo. Proc. Natl. Acad. Sci. USA. 80:1983;3372-3376.
18. j mutation contains an intragenic deletion of the Gli3 gene. Nat. Genet. 3:1993;241-246.
19. Husoy A., Myers M. S., Willis M. L., Collier T. K., Celander M., Goksoyr A. Immunohistochemical localization of CYP1A and CYP3A-like isozymes in hepatic and extrahepatic tissues of Atlantic cod (Gadus morhua L.), a marine fish. Toxicol. Appl. Pharmacol. 129:1994;294-308.
20. Kapitulnik J., Gelboin H. V., Guengerich F. P., Jacobowitz D. M. Immunohistochemical localization of cytochrome-450 in rat brain. Neuroscience. 20:1987;829-833.
21. Laethem R. M., Koop D. R. Identification of rabbit cytochromes P450 and 2C1 and 2C2 as arachidonic acid epoxygenases. Mol. Pharmacol. 42:1992;958-963.
22. Laethem R. M., Laethem C. L., Ding X., Koop D. E. P-450 dependent arachidonic acid metabolism in rabbit olfactory microsomes. J. Pharmacol. Exp. Ther. 262:1992;433-438.
23. Mahajan S. S., Rifkind A. B. Transcriptional activation of avian CYP1A4 and CYP1A5 by 2,3,7,8-tetrachlorodibenzo-p-dioxin; differences in gene expression and regulation compared to mammalian CYP1A1 and CYP1A2. Toxicol. Appl. Pharmacol. 155:1999;96-106.
24. Matsuda T., Imaoka S., Funae Y., Otori K., Fukushima S. Induction of CYP isoenzymes in various organs of rats by 3-methylcholanthrene or β-naphthoflavone. Cancer Lett. 97:1995;137-143.
25. McGiff J. C., Steinberg M., Quilley J. Missing links: Cytochrome P450 arachidonate products. A new class of lipid mediators. Trends Cardiovasc. Med. 6:1996;4-10.
26. Morrison H. G., Oleksiak M. F., Cornell N. W., Sogin M. L., Stegeman J. J. Identification of cytochrome P450 (CYP1A1) genes from two teleost fish, toadfish (Opsanus tau) and scup (Stenotomus chrysopus), and phylogentic analysis of CYP1A1 genes. Biochem. J. 308:1995;97-104.
27. Nakai K., Ward A. M., Gannon M., Rifkind A. B. β-Naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase. J. Biol. Chem. 267:1992;19503-19512.
28. Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1-42.
29. Okey A. B., Riddick D. S., Harper P. A. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol. Sci. 15:1994;226-232.
30. Ou X., Ramos K. S. Regulation of cytochrome P4501A1 gene expression in vascular smooth muscle cells through aryl hydrocarbon receptor-mediated signal transduction requires a protein synthesis inhibitor. Arch. Biochem. Biophys. 316:1995;116-122.
31. Overby L. H., Nishio S., Weir A., Carver G. T., Plopper C. G., Philpot R. M. Distribution of cytochrome P4501A1 and NADPH-cytochrome P450 reductase in lungs of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: Ultrastructural immunolocalization and in situ hybridization. Mol. Pharmacol. 41:1992;1039-1046.
32. Poland A., Knutson J. C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related polyhalogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Ann. Rev. Pharmacol. Toxicol. 22:1982;517-554.
33. Popp R., Bauersachs J., Hecker M., Fleming I., Busse R. A transferable β-naphthoflavone-inducible hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J. Physiol. 497:1996;699-709.
34. Rifkind A. B., Kanetoshi A., Orlinick J., Capdevila J. H., Lee C. Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J. Biol. Chem. 269:1994;3387-3396.
35. Rifkind A. B., Lee C., Chang T. K. H., Waxman D. J. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1 and 1A2. Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320:1995;380-389.
36. Santostefano M. J., Johnson K. L., Whisnant N. A., Richardson V. M., DeVito M. J., Diliberto J. J., Birnbaum L. S. Subcellular localization of TCDD differs between the liver, lungs and kidneys after acute and subchronic exposure: Species/dose comparisons and possible mechanism. Toxicol. Appl. Pharmacol. 34:1996;265-275.
37. Schmidt J. V., Bradfield C. A. Ah receptor signalling pathways. Annu. Rev. Cell. Dev. Biol. 12:1996;55-89.
38. Sesardic D., Cole K. J., Edwards R. J., Davies D. S., Thomas P. E., Levin W., Boobis A. R. The inducibility and catalytic activity of cytochromes P450c(P4501A1) and P450d (P4501A2) in rat tissues. Biochem. Pharmacol. 39:1990;499-506.
39. Stegeman J. J., Hahn M. E., Weisbrod R., Woodin B. R., Joy J. S., Najibi S., Cohen R. A. Induction of cytochrome P4501A1 by aryl hydrocarbon recetor agonists in porcine aorta endothelial cells in culture and ctyochrome P4501A1 activity in intact cells. Mol. Pharmacol. 47:1995;296-306.
40. Stegeman J. J., Smolowitz R. M., Hahn M. E. Immunohistochemical localization of environmentally induced cytochrome P4501A1 in multiple organs of the marine teleost Stenotomus chrysops (scup). Toxicol. Appl. Pharmicol. 110:1991;486-504.
41. Takahashi Y., Suzuki C., Kamataki T. Silencing of CYP1A1 expression in rabbits by DNA methylation. Biochem. Biophys. Res. Commun. 247:1998;383-386.
42. Thirman M. J., Albrecht J. H., Krueger M. A., Erickson R. R., Cherwitz D. L., Park S. S., Gelboin H. V., Holtzman J. L. Induction of cytochrome CYP1A1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: A possible role in atherogenesis. Proc. Natl. Acad. Sci. USA. 91:1994;5397-5401.
43. Tian H., McKnight S. L., Russell D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11:1997;72-82.
44. Toborek M., Barger S. W., Mattson M. P., Espandiari P., Robertson L. W., Hennig B. Exposure to polychlorinated biphenyls causes endothelial cell dysfunction. J. Biochem. Toxicol. 10:1995;219-226.
45. 3-450 cDNA clone. Biochemistry. 23:1984;6003-6008.
46. Walker M. K., Pollenz R. S., Smith S. M. Expression of the aryl hydrocarbon receptor (AhR) and Ah receptor nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol. Appl. Pharmacol. 143:1997;407-419.
47. Wood, E, Bahk, K, Lanahan, J, Gilday, D, and, Rifkind, A. B, unpublished manuscript.